Publications by authors named "Nicholas A Zorko"

Claim this Profile
C
Correction: Natural killer cell infiltration in prostate cancers predict improved patient outcomes.
Nicholas A Zorko, Allison Makovec, Andrew Elliott, Samuel Kellen, John R Lozada

Prostate Cancer Prostatic Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HLA class I expression shapes the tumor immune microenvironment and influences prognosis in prostate cancer.
Pornlada Likasitwatanakul, Carissa Besonen, Alexander K Tsai, Negar Sadeghipour, Andrew Elliott, Nicholas A Zorko

Prostate Cancer Prostatic Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel trispecific killer engager targeting B7-H3 enhances natural killer cell antitumor activity against head and neck cancer.
Melissa J Khaw, Nicholas A Zorko, Philippa R Kennedy, Laura E Bendzick, Madison Shackelford

J Immunother Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural Killer Cell Infiltration in Prostate Cancers Predict Improved Patient Outcomes.
Nicholas A Zorko, Allison Makovec, Andrew Elliott, Samuel Kellen, John R Lozada

Prostate Cancer Prostatic Dis· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A PSMA-Targeted Tri-Specific Killer Engager Enhances NK Cell Cytotoxicity against Prostate Cancer.
Shee Kwan Phung, Nicholas A Zorko, Yvette Soignier, Rhett L Waller, Madison Shackelford

Cancer Immunol Res· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression Patterns of DLL3 across Neuroendocrine and Non-neuroendocrine Neoplasms Reveal Broad Opportunities for Therapeutic Targeting.
John R Lozada, Andrew Elliott, Mark G Evans, James Wacker, Kathleen M Storey, Nicholas A Zorko

Cancer Res Commun· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disrupting prostate cancer research: Challenge accepted; report from the 2023 Coffey-Holden Prostate Cancer Academy Meeting.
Andrea K Miyahira, Sophia C Kamran, Tamara Jamaspishvili, Catherine H Marshall, Kara N Maxwell, Nicholas A Zorko

Prostate· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pan-Cancer Interrogation of B7-H3 (CD276) as an Actionable Therapeutic Target Across Human Malignancies.
Carly D Miller, John R Lozada, Nicholas A Zorko, Andrew Elliott, Allison Makovec

Cancer Res Commun· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes in patients with metastatic castrate-resistant prostate cancer treated with abiraterone with or without ongoing androgen deprivation therapy: A retrospective case-control study.
Ali T Arafa, Leah R Blader, Karan Ramakrishna, Jeff Engle, Charles J Ryan, Nicholas A Zorko

Prostate· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastatic Castration-Resistant Prostate Cancer, Immune Checkpoint Inhibitors, and Beyond.
Sree M Lanka, Nicholas A Zorko, Emmanuel S Antonarakis, Pedro C Barata

Curr Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel immune engagers and cellular therapies for metastatic castration-resistant prostate cancer: do we take a BiTe or ride BiKEs, TriKEs, and CARs?
Nicholas A Zorko, Charles J Ryan

Prostate Cancer Prostatic Dis· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NK-Cell-Mediated Targeting of Various Solid Tumors Using a B7-H3 Tri-Specific Killer Engager In Vitro and In Vivo.
Daniel A Vallera, Soldano Ferrone, Behiye Kodal, Peter Hinderlie, Laura Bendzick, Nicholas A Zorko

Cancers (Basel)· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eradicating acute myeloid leukemia in a Mll(PTD/wt):Flt3(ITD/wt) murine model: a path to novel therapeutic approaches for human disease.
Kelsie M Bernot, John S Nemer, Ramasamy Santhanam, Shujun Liu, Nicholas A Zorko

Blood· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mll partial tandem duplication and Flt3 internal tandem duplication in a double knock-in mouse recapitulates features of counterpart human acute myeloid leukemias.
Nicholas A Zorko, Kelsie M Bernot, Susan P Whitman, Ronald F Siebenaler, Elshafa H Ahmed

Blood· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical neonatal rat studies of heparin-binding EGF-like growth factor in protection of the intestines from necrotizing enterocolitis.
Andrei Radulescu, Nicholas A Zorko, Xiaoyi Yu, Gail E Besner

Pediatr Res· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis